Carna Biosciences Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,483	516	2,108	2,889	3,379	3,817
Cash & Short-Term Investments	1,483	516	2,108	2,889	3,379	3,817
Cash Growth	-3.03%	-75.52%	-27.03%	-14.50%	-11.47%	-11.21%
Receivables	117	100	87	788	182	1,243
Inventory	154	154	154	140	118	110
Prepaid Expenses	51	66	-	-	-	-
Other Current Assets	355	339	388	374	425	148
Total Current Assets	2,160	1,175	2,737	4,191	4,104	5,318
Property, Plant & Equipment	-	-	-	105	100	51
Long-Term Investments	53	54	34	51	59	59
Other Intangible Assets	-	-	-	1	1	2
Other Long-Term Assets	-	-	1	1	2	2
Total Assets	2,213	1,229	2,772	4,349	4,266	5,432
Accounts Payable	-	-	2	1	1	2
Current Portion of Long-Term Debt	3	8	19	120	151	239
Current Portion of Leases	8	8	8	6	-	-
Current Income Taxes Payable	105	140	180	218	265	332
Current Unearned Revenue	-	-	-	-	-	177
Other Current Liabilities	18	12	13	30	19	24
Total Current Liabilities	134	168	222	375	436	774
Long-Term Debt	2,173	681	8	28	148	300
Long-Term Leases	14	16	24	28	-	-
Other Long-Term Liabilities	55	56	44	42	42	45
Total Liabilities	2,376	921	298	473	626	1,119
Common Stock	24	14	2,447	2,076	1,382	1,056
Additional Paid-In Capital	2,206	2,196	6,198	5,827	5,133	4,808
Retained Earnings	-2,493	-1,980	-6,253	-4,075	-2,922	-1,572
Comprehensive Income & Other	100	78	82	48	47	21
Shareholders' Equity	-163	308	2,474	3,876	3,640	4,313
Total Liabilities & Equity	2,213	1,229	2,772	4,349	4,266	5,432
Total Debt	2,198	713	59	182	299	539
Net Cash (Debt)	-715	-197	2,049	2,707	3,080	3,278
Net Cash Growth	-	-	-24.31%	-12.11%	-6.04%	-15.32%
Net Cash Per Share	-37.38	-10.31	114.41	161.13	226.18	258.20
Filing Date Shares Outstanding	19.16	19.19	19.1	17.14	16.34	13.48
Total Common Shares Outstanding	19.16	19.14	19.1	17.14	14.21	13.31
Working Capital	2,026	1,007	2,515	3,816	3,668	4,544
Book Value Per Share	-8.51	16.09	129.55	226.07	256.14	324.08
Tangible Book Value	-163	308	2,474	3,875	3,639	4,311
Tangible Book Value Per Share	-8.51	16.09	129.55	226.02	256.07	323.93
Order Backlog	-	23.01	13.09	39.76	58.12	257.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.